eBooks
Experts Insights: Development Allogenic CAR - T Cells
lthough autologous therapies offer great advantages in terms of host compatibility, their manufacturing presents challenges along several parameters, including control strategy and supply chain.
Experts’ Insights: Automation Strategies for CAR-T Therapy Manufacturing
CAR-T therapies have shown tremendous clinical potential. However, the manufacturing remains challenging due to the lack of control and automation as well as process and cell product characterization during process development and manufacturing stages
Our granulation machines just work. And they'll keep on working, even after an explosion
A dust- or solvent-based explosion in your granulation line not only endangers the safety of your personnel and facilities but can also destroy your equipment.
Importance of mAb Discovery and Development in Immunotherapy
More Insight, Better Decisions for Monoclonal Antibody (mAb) Therapy Discovery and Development
Bioprocessing Basics
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid, sample, and cell handling in laboratories worldwide.
For Problem - Solving innovation,our granulation machines really clean up!
During the granulation process, cleaning is a critical part of preventing cross-batch contamination and ensuring consistent and high quality outputs.
Our granulation solution read almost like an A-Z. Let's start with Z
When ACG’s design engineers at Xertecs in Müllheim (Germany) created our granulation equipment, they considered every detail.
Reduce Your Risk of GMP Audit Citations
The US Food and Drug Administration (FDA) is responsible for ensuring the quality of medicines that are supplied to the American market.
Efficient Purification for Next-Gen Antibodies
Discover innovative techniques to overcome purification challenges in monoclonal and next-gen antibodies
Resource guide for overcoming analytical challenges in cell therapy
A practical guide to streamlining safety, purity, potency, and identity testing across the cell therapy lifecycle.
